The US FDA has made updates to the Revlimid [lenalidomide] label, similar to those announced recently by Health Canada.

Author:  

Publisher: Adis International

ISSN: 0114-9954

Source: Reactions Weekly, Vol.1, Iss.1402, 2012-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract